President of Credo-TM Joins Neuro-Biotech Corp. Board of Directors

BASEL, Switzerland, March 24 /PRNewswire-FirstCall/ - Neuro-Biotech Corp. (PINKSHEETS: MRES) (OTCQB: MRES) is pleased to announce that effective immediately, the president of Credo-TM, Mr Rustern Yusupov, will assume the position of Vice-President Marketing. Mr Yusupov will be based out of Credo-TM`s head office in Kazan, Russia. Mr Yusupov will help lead the implementation of Neuro-Biotech licensees' network, particularly in the creation of its own "Technological Showcase" to support the training of technicians as well as the developments of new products.

Mr. Yusupov has an extensive experience in Internet and media advertising. Mr Yusupov is currently the Chief Executive Officer of Credo-TM, a corporation that developed, with the help of government grants, a solid distribution network of advanced and modern medical products. Mr Yusupov`s company currently employs more than 300 individuals. Over the years, Mr. Yusupov has served on the boards of directors of private companies. Mr Yusupov graduated in 1994 from the Kazan Aviation University.

"I am excited to be joining a company that develops products I believe in and have advocated for among my distribution network. This is a great opportunity for me to contribute to its continued strategic success." stated Yusupov.

For more information on Neuro-Biotech Corp or to contact a company representative, please visit: www.neuro-biotechcorp.com

FORWARD LOOKING STATEMENTS

This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

SOURCE Neuro-Biotech Corp.

Copyright h 24 PR Newswire